自拟中药方肺心安联合西药治疗气阴两虚型慢性阻塞性肺疾病稳定期30例疗效观察  

Clinical observation of Feixin’an a self-made Chinese medicine formula in treating 30 cases of chronic obstructive pulmonary disease of deficiency of qi and yin in stable stage

作　　者：董珍宇[1] 曹锐[1] 李文泉[1] 权红[1] DONG Zhen-yu;CAO Rui;LI Wen-quan;QUAN Hong(Department of Traditional Chinese medicine,Beijing Chaoyang Hospital Afiliated to the Capital Medical University,Bejing 100020,China)

机构地区：[1]首都医科大学附属北京朝阳医院中医科,北京100020

出　　处：《北京中医药》2022年第8期907-911,共5页Beijing Journal of Traditional Chinese Medicine

基　　金：北京中医药科技发展资金项目(JJ2018-43);第七批全国老中医药专家学术经验继承工作项目(国家中医药管理局国中医药人教函[2022]76号);全国名老中医药专家传承工作室建设项目(国家中医药管理局国中医药人教函[2018]134号)。

摘　　要：目的 观察肺心安治疗气阴两虚型慢性阻塞性肺疾病(COPD)稳定期的临床疗效。方法 选择2019年1月—2020年12月首都医科大学附属北京朝阳医院中医科门诊及病房收治的气阴两虚型COPD稳定期患者60例,肺功能Ⅱ~Ⅲ级,随机分为对照组与试验组,每组30例。对照组予西医基础治疗,试验组在西药基础上加肺心安,1袋/次,2次/d,12周为1个疗程,随访6个月。比较2组疗效,治疗前后中医证候积分、COPD评估测试(CAT)评分、改良英国医学研究学会呼吸困难指数量表(mMRC)评分、急性加重次数、实验室指标及不良反应。结果 试验组总有效率96.67%,高于对照组83.33%,差异有统计学意义(P<0.05)。治疗后,2组中医证候总积分、CAT评分、mMRC评分、血清缺氧诱导因子(HIF-1α)水平均较治疗前降低(P<0.05),血清1,25-二羟维生素D[1,25 (OH)D]水平均较治疗前升高(P<0.05),且试验组以上指标优于对照组,差异有统计学意义(P<0.05)。所有患者治疗后均未见明显不良反应。结论 肺心安联合西医基础治疗气阴两虚型COPD稳定期患者能够提高临床疗效,改善临床症状,减少急性加重次数。Objective To observe the effect of Feixin’an in treating chronic obstructive pulmonary disease(COPD) of deficiency of Qi and Yin in the stable stage.Methods A total of 60 COPD patients in stable stage of deficiency of Qi and Yin with Grade Ⅱ to Ⅲ lung function treated in Department of TCM of Beijing Chaoyang Hospital Affiliated to the Capital Medical University from January 2019 to December 2020 were randomly divided into a control group and an observation group with 30 cases in each group.The control group was treated with routine western medicine.On the basis of the routine western medicine,the observation group was also given Feixin’an with one bag each time, twice a day,12 weeks as a course, and follow-up for 6 months.The TCM clinical syndromes score, CAT score,mMRC score, acute aggravation times, laboratory indexes and adverse reactions in 2 groups were observed and compared before and after the treatment.Results The effective rate of the observation group was 96.67%, which was higher than that of the control group(P<0.05) which was 83.33%, and the difference was statistically significant(P<0.05).After the treatment, TCM clinical syndromes score, CAT score, mMRC score and HIF-1α were more obviously alleviated than that before the treatment(P<0.05), serum 1,25-dihydroxyvitamin D[1,25(OH)D] were increased than that before the treatment in both two groups, the index of the experimental group was better than that of the control group and the difference was statistically significant(P<0.05) No adverse reactions were found in both groups.Conclusion Feixin’an combined with routine treatment can enhance the clinical effect of chronic obstructive pulmonary disease(COPD) of deficiency of Qi and Yin in the stable stage,improve TCM symptoms,reduce the acute aggravation and improve the quality of life.

关 键 词：肺心安 慢性阻塞性肺疾病 稳定期 气阴两虚型 

分 类 号：R563.9[医药卫生—呼吸系统]